XML 68 R55.htm IDEA: XBRL DOCUMENT v3.7.0.1
Segment Information (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Segment Reporting Information      
Assets $ 70,887   $ 52,666
Net Sales to External Customers 6,335 $ 4,885  
Operating Earnings (202) 524  
Amortization of intangible assets (522) (144)  
Earnings from continuing operations before tax $ 736 2  
Annual share-based awards recognized in first quarter (as a percent) 50.00%    
Foreign currency exchange loss on remeasurement   477  
Venezuela      
Segment Reporting Information      
Foreign currency exchange loss on remeasurement   477  
Other      
Segment Reporting Information      
Net Sales to External Customers $ 482 523  
Non-reportable segment      
Segment Reporting Information      
Impairment of indefinite-lived intangible assets   43  
Total Reportable Segments      
Segment Reporting Information      
Net Sales to External Customers 5,853 4,362  
Operating Earnings 1,491 1,004  
Total Reportable Segments | Established Pharmaceutical Products      
Segment Reporting Information      
Net Sales to External Customers 950 888  
Operating Earnings 140 148  
Total Reportable Segments | Nutritional Products      
Segment Reporting Information      
Net Sales to External Customers 1,642 1,671  
Operating Earnings 351 342  
Total Reportable Segments | Diagnostic Products      
Segment Reporting Information      
Net Sales to External Customers 1,158 1,118  
Operating Earnings 284 267  
Total Reportable Segments | Cardiovascular and Neuromodulation Products      
Segment Reporting Information      
Net Sales to External Customers 2,103 685  
Operating Earnings 716 247  
Corporate functions      
Segment Reporting Information      
Corporate functions and benefit plans costs (190) (81)  
Reconciling items      
Segment Reporting Information      
Non-reportable segments 46 (2)  
Net interest expense (204) (25)  
Share-based compensation (171) (152)  
Amortization of intangible assets (522) (144)  
Other, net 286 $ (598)  
St Jude Medical | Cardiovascular and Neuromodulation Products      
Segment Reporting Information      
Assets $ 5,162   $ 1,425